MIJ821 (onfasprodil) in healthy volunteers: First-in-human, randomized, placebo-controlled study (single ascending dose and repeated intravenous dose).
- DOI
- 10.1111/cts.13623
- Published
- 2023 Nov
- Container
- Clinical and translational science
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/cts.13623,
title = {MIJ821 (onfasprodil) in healthy volunteers: First-in-human, randomized, placebo-controlled study (single ascending dose and repeated intravenous dose).},
author = {Gomez-Mancilla B and Levy JA and Ganesan S and Faller T and Issachar G and Peremen Z and Laufer O and Shani-Hershkovich R and Biliouris K and Walker E and Healy MP and Sverdlov O and Desai S and Ghaemi SN and Cha JH and Shanker YG},
year = {2023},
journal = {Clinical and translational science},
doi = {10.1111/cts.13623},
url = {https://doi.org/10.1111/cts.13623}
}RIS
TY - JOUR TI - MIJ821 (onfasprodil) in healthy volunteers: First-in-human, randomized, placebo-controlled study (single ascending dose and repeated intravenous dose). AU - Gomez-Mancilla B AU - Levy JA AU - Ganesan S AU - Faller T AU - Issachar G AU - Peremen Z AU - Laufer O AU - Shani-Hershkovich R AU - Biliouris K AU - Walker E AU - Healy MP AU - Sverdlov O AU - Desai S AU - Ghaemi SN AU - Cha JH AU - Shanker YG PY - 2023 JO - Clinical and translational science DO - 10.1111/cts.13623 UR - https://doi.org/10.1111/cts.13623 ER -
APA
B, G., JA, L., S, G., T, F., G, I., Z, P., O, L., R, S., K, B., E, W., MP, H., O, S., S, D., SN, G., JH, C., & YG, S. (2023). MIJ821 (onfasprodil) in healthy volunteers: First-in-human, randomized, placebo-controlled study (single ascending dose and repeated intravenous dose).. Clinical and translational science. https://doi.org/10.1111/cts.13623
Source records
- pubmed · retrieved 2026-09-26T05:55:53.046Z